DE69929959D1 - Zubereitungen enthaltend mikropartikel von wasserunlöslichen substanzen, sowie verfahren zu deren herstellung - Google Patents

Zubereitungen enthaltend mikropartikel von wasserunlöslichen substanzen, sowie verfahren zu deren herstellung

Info

Publication number
DE69929959D1
DE69929959D1 DE69929959T DE69929959T DE69929959D1 DE 69929959 D1 DE69929959 D1 DE 69929959D1 DE 69929959 T DE69929959 T DE 69929959T DE 69929959 T DE69929959 T DE 69929959T DE 69929959 D1 DE69929959 D1 DE 69929959D1
Authority
DE
Germany
Prior art keywords
micron
water
block copolymer
particles
stabilization
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69929959T
Other languages
English (en)
Other versions
DE69929959T2 (de
Inventor
Sheema Khan
W Pace
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Jagotec AG
Original Assignee
Jagotec AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jagotec AG filed Critical Jagotec AG
Publication of DE69929959D1 publication Critical patent/DE69929959D1/de
Application granted granted Critical
Publication of DE69929959T2 publication Critical patent/DE69929959T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/902—Specified use of nanostructure
    • Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
    • Y10S977/926—Topical chemical, e.g. cosmetic or sunscreen

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Nanotechnology (AREA)
  • Optics & Photonics (AREA)
  • Medicinal Preparation (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
DE69929959T 1998-03-30 1999-03-29 Zubereitungen enthaltend mikropartikel von wasserunlöslichen substanzen, sowie verfahren zu deren herstellung Expired - Lifetime DE69929959T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US7980998P 1998-03-30 1998-03-30
US79809P 1998-03-30
PCT/US1999/006746 WO1999049846A2 (en) 1998-03-30 1999-03-29 Compositions containing microparticles of water-insoluble substances and method for their preparation

Publications (2)

Publication Number Publication Date
DE69929959D1 true DE69929959D1 (de) 2006-04-27
DE69929959T2 DE69929959T2 (de) 2006-11-02

Family

ID=22152962

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69929959T Expired - Lifetime DE69929959T2 (de) 1998-03-30 1999-03-29 Zubereitungen enthaltend mikropartikel von wasserunlöslichen substanzen, sowie verfahren zu deren herstellung

Country Status (14)

Country Link
US (1) US6387409B1 (de)
EP (1) EP1067914B1 (de)
JP (2) JP4709378B2 (de)
KR (1) KR100628341B1 (de)
CN (1) CN1303278B (de)
AT (1) ATE318132T1 (de)
AU (1) AU761205B2 (de)
CA (1) CA2326456C (de)
DE (1) DE69929959T2 (de)
ES (1) ES2257041T3 (de)
IL (3) IL138765A0 (de)
SE (1) SE0003429L (de)
TW (1) TWI267383B (de)
WO (1) WO1999049846A2 (de)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6465016B2 (en) 1996-08-22 2002-10-15 Research Triangle Pharmaceuticals Cyclosporiine particles
CN1303278B (zh) * 1998-03-30 2010-06-23 斯凯伊药品加拿大公司 制备水不溶性物质微粒的组合物和方法
WO1999061001A1 (en) 1998-05-29 1999-12-02 Rtp Pharma Inc. Thermoprotected microparticle compositions and process for terminal steam sterilization thereof
AU767154B2 (en) 1998-11-20 2003-10-30 Skyepharma Canada Inc. Dispersible phospholipid stabilized microparticles
IL143196A0 (en) * 1998-11-20 2002-04-21 Rtp Pharma Inc Method of preparing stable suspensions of insoluble microparticles
CA2383233C (en) * 1999-09-21 2010-06-08 Rtp Pharma Inc. Surface modified particulate compositions of biologically active substances
US20080241070A1 (en) * 2000-09-21 2008-10-02 Elan Pharma International Ltd. Fenofibrate dosage forms
US20030224058A1 (en) * 2002-05-24 2003-12-04 Elan Pharma International, Ltd. Nanoparticulate fibrate formulations
US7276249B2 (en) * 2002-05-24 2007-10-02 Elan Pharma International, Ltd. Nanoparticulate fibrate formulations
US8067032B2 (en) 2000-12-22 2011-11-29 Baxter International Inc. Method for preparing submicron particles of antineoplastic agents
US9700866B2 (en) 2000-12-22 2017-07-11 Baxter International Inc. Surfactant systems for delivery of organic compounds
US20030054042A1 (en) * 2001-09-14 2003-03-20 Elaine Liversidge Stabilization of chemical compounds using nanoparticulate formulations
US20060003012A9 (en) 2001-09-26 2006-01-05 Sean Brynjelsen Preparation of submicron solid particle suspensions by sonication of multiphase systems
JP2005504090A (ja) 2001-09-26 2005-02-10 バクスター・インターナショナル・インコーポレイテッド 分散体および溶媒相または液相の除去によるサブミクロンサイズ−ナノ粒子の調製
US7112340B2 (en) * 2001-10-19 2006-09-26 Baxter International Inc. Compositions of and method for preparing stable particles in a frozen aqueous matrix
ES2320438T7 (es) 2002-04-09 2013-02-14 Flamel Technologies Formulación farmaceútica oral de suspensión acuosa de microcápsulas que permiten la liberación modificada de principio(s) activo(s)
US20070264348A1 (en) * 2002-05-24 2007-11-15 Elan Pharma International, Ltd. Nanoparticulate fibrate formulations
FR2842735B1 (fr) 2002-07-26 2006-01-06 Flamel Tech Sa Microcapsules a liberation modifiee de principes actifs peu solubles pour l'administration per os
FR2842736B1 (fr) 2002-07-26 2005-07-22 Flamel Tech Sa Formulation pharmaceutique orale sous forme d'une pluralite de microcapsules permettant la liberation prolongee de principe(s) actif(s) peu soluble(s)
CN1243538C (zh) * 2002-11-21 2006-03-01 武汉利元亨药物技术有限公司 熊果酸豆磷脂纳米粒冻干粉针及制备方法
GB0302672D0 (en) * 2003-02-06 2003-03-12 Astrazeneca Ab Pharmaceutical formulations
US6931888B2 (en) * 2003-02-07 2005-08-23 Ferro Corporation Lyophilization method and apparatus for producing particles
US20040178135A1 (en) * 2003-03-13 2004-09-16 Beplate Douglas K. Filtering device incorporating nanoparticles
MXPA05012467A (es) * 2003-05-19 2006-02-22 Baxter Int Particulas solidas que comprenden un anticonvulsivo o un inmunosupresor revestido con uno o mas modificadores de superficie.
US20050170004A1 (en) * 2003-10-31 2005-08-04 Vered Rosenberger Nanoparticles for drug delivery
US20060141049A1 (en) * 2003-11-12 2006-06-29 Allergan, Inc. Triamcinolone compositions for intravitreal administration to treat ocular conditions
US20050101582A1 (en) 2003-11-12 2005-05-12 Allergan, Inc. Compositions and methods for treating a posterior segment of an eye
US20070224278A1 (en) 2003-11-12 2007-09-27 Lyons Robert T Low immunogenicity corticosteroid compositions
AU2005209201B2 (en) 2004-01-20 2010-06-03 Allergan, Inc. Compositions for localized therapy of the eye, comprising preferably triamcinolone acetonide and hyaluronic acid
US20050170063A1 (en) * 2004-01-29 2005-08-04 Lalit Chordia Production of powder and viscous material
US8147865B2 (en) 2004-04-30 2012-04-03 Allergan, Inc. Steroid-containing sustained release intraocular implants and related methods
US8119154B2 (en) 2004-04-30 2012-02-21 Allergan, Inc. Sustained release intraocular implants and related methods
AU2005271700B2 (en) * 2004-07-12 2010-11-11 Allergan, Inc. Opthalmic compositions and methods for treating ophthalmic conditions
WO2006043965A1 (en) * 2004-10-14 2006-04-27 Allergan, Inc. Therapeutic ophthalmic compositions containing retinal friendly excipients and related methods
EP1815869A4 (de) * 2004-11-24 2011-04-06 Nanocarrier Co Ltd Verfahren zur veränderung der morphologie von blockcopolymeren
EP1906973A2 (de) * 2005-06-14 2008-04-09 Baxter International Inc. Pharmazeutische formulierungen zur minimierung von arzneimittel-wechselwirkungen
WO2007008697A2 (en) * 2005-07-08 2007-01-18 University Of Chicago Compositions and methods for refolding of denatured proteins
US20070134341A1 (en) * 2005-11-15 2007-06-14 Kipp James E Compositions of lipoxygenase inhibitors
US20090152176A1 (en) * 2006-12-23 2009-06-18 Baxter International Inc. Magnetic separation of fine particles from compositions
US8426467B2 (en) * 2007-05-22 2013-04-23 Baxter International Inc. Colored esmolol concentrate
US8722736B2 (en) * 2007-05-22 2014-05-13 Baxter International Inc. Multi-dose concentrate esmolol with benzyl alcohol
US20080293814A1 (en) * 2007-05-22 2008-11-27 Deepak Tiwari Concentrate esmolol
HUE036214T2 (hu) * 2007-07-31 2018-06-28 Otsuka Pharma Co Ltd Eljárások aripiprazol-szuszpenzió és fagyasztva szárított készítmény elõállítására
WO2009042114A2 (en) 2007-09-21 2009-04-02 The Johns Hopkins University Phenazine derivatives and uses thereof
CN103228266B (zh) 2010-10-29 2017-11-14 健康科学西部大学 三元混合物制剂
US20140000540A1 (en) * 2012-06-27 2014-01-02 Shell Oil Company Fuel and engine oil composition and its use

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5091187A (en) 1990-04-26 1992-02-25 Haynes Duncan H Phospholipid-coated microcrystals: injectable formulations of water-insoluble drugs
US5145684A (en) 1991-01-25 1992-09-08 Sterling Drug Inc. Surface modified drug nanoparticles
MX9201782A (es) 1991-04-19 1992-10-01 Sandoz Ag Particulas de sustancias biologicamente activas, sustancialmente insolubles en agua, proceso para su produccion y composicion farmaceutica que las contiene.
US5298262A (en) 1992-12-04 1994-03-29 Sterling Winthrop Inc. Use of ionic cloud point modifiers to prevent particle aggregation during sterilization
US5340564A (en) 1992-12-10 1994-08-23 Sterling Winthrop Inc. Formulations comprising olin 10-G to prevent particle aggregation and increase stability
US5336507A (en) 1992-12-11 1994-08-09 Sterling Winthrop Inc. Use of charged phospholipids to reduce nanoparticle aggregation
US5326552A (en) 1992-12-17 1994-07-05 Sterling Winthrop Inc. Formulations for nanoparticulate x-ray blood pool contrast agents using high molecular weight nonionic surfactants
DE4440337A1 (de) 1994-11-11 1996-05-15 Dds Drug Delivery Services Ges Pharmazeutische Nanosuspensionen zur Arzneistoffapplikation als Systeme mit erhöhter Sättigungslöslichkeit und Lösungsgeschwindigkeit
US5569448A (en) 1995-01-24 1996-10-29 Nano Systems L.L.C. Sulfated nonionic block copolymer surfactants as stabilizer coatings for nanoparticle compositions
AU4862796A (en) * 1995-02-06 1996-08-27 Nanosystems L.L.C. Formulations of compounds as nanoparticulate dispersions in digestible oils or fatty acids
US5510118A (en) 1995-02-14 1996-04-23 Nanosystems Llc Process for preparing therapeutic compositions containing nanoparticles
DE69637441T2 (de) * 1995-10-17 2009-03-05 Jagotec Ag Verabreichung unlöslicher arzneistoffe
US5686133A (en) 1996-01-31 1997-11-11 Port Systems, L.L.C. Water soluble pharmaceutical coating and method for producing coated pharmaceuticals
AU719085B2 (en) * 1996-08-22 2000-05-04 Rtp Pharma Corporation Processes of preparing or stabilising microparticles
WO1999029300A1 (en) * 1997-12-10 1999-06-17 Rtp Pharma Inc. Self-emulsifying fenofibrate formulations
CN1303278B (zh) * 1998-03-30 2010-06-23 斯凯伊药品加拿大公司 制备水不溶性物质微粒的组合物和方法
JPWO2013047199A1 (ja) * 2011-09-30 2015-03-26 Jx日鉱日石金属株式会社 スパッタリングターゲット及びその製造方法

Also Published As

Publication number Publication date
US6387409B1 (en) 2002-05-14
AU761205B2 (en) 2003-05-29
IL138765A0 (en) 2001-10-31
AU3118599A (en) 1999-10-18
CA2326456A1 (en) 1999-10-07
JP5539839B2 (ja) 2014-07-02
KR20010042103A (ko) 2001-05-25
CA2326456C (en) 2008-12-23
KR100628341B1 (ko) 2006-09-27
WO1999049846A2 (en) 1999-10-07
JP2011037889A (ja) 2011-02-24
SE0003429L (sv) 2000-11-23
IL138765A (en) 2007-09-20
CN1303278A (zh) 2001-07-11
JP4709378B2 (ja) 2011-06-22
WO1999049846A3 (en) 1999-11-18
CN1303278B (zh) 2010-06-23
ATE318132T1 (de) 2006-03-15
IL162023A0 (en) 2005-11-20
SE0003429D0 (sv) 2000-09-26
EP1067914B1 (de) 2006-02-22
DE69929959T2 (de) 2006-11-02
TWI267383B (en) 2006-12-01
EP1067914A2 (de) 2001-01-17
JP2002509876A (ja) 2002-04-02
ES2257041T3 (es) 2006-07-16

Similar Documents

Publication Publication Date Title
ATE318132T1 (de) Zubereitungen enthaltend mikropartikel von wasserunlöslichen substanzen, sowie verfahren zu deren herstellung
ATE297196T1 (de) Verfahren zur herstellung von nanometer partikeln durch fliessbett- sprühtrocknung
EP0038979B1 (de) Verfahren zur Herstellung von Äthylcellulose-Mikrokapseln
CA2215254A1 (fr) Particules a base de polyaminoacide(s) et susceptibles d'etre utilisees comme vecteurs de principe(s) actif(s) et leurs procedes de preparation
MY108134A (en) Surface modified drug nanoparticles
Bariana et al. Tailoring morphological and interfacial properties of diatom silica microparticles for drug delivery applications
ES2069995T5 (es) Mejoras en composiciones farmaceuticas.
ATE420630T1 (de) Pulverzubereitungen und verfahren zu ihrer herstellung
DE69635578D1 (de) Verfahren und system zur behandlung dispergierbarer feiner pulver
AR016686A1 (es) Composicion farmaceutica adecuada como una formulacion de deposito para la administracion por inyeccion intramuscular o subcutanea y uso de la misma parala manufactura de un medicamento.
DE60027292D1 (de) Erniedrigung von mineralsalzabsetzung
DE69734988D1 (de) Zubereitungen enthaltend mikropartikel von wasserunlöslichen stoffen und verfahren zu deren herstellung
ES2179851T3 (es) Suspension de etabonato de loteprednol.
CA2413767A1 (en) Ph-regulated polyamide powder for cosmetic applications
ATE315605T1 (de) Polyakrylsäure-granulate mit gesteuerter freigabe und verfahren zu dessen herstellung
CO4980893A1 (es) Granulos que comprenden clavulanato y excipientes
MX170378B (es) Procedimiento para revestir granulos de detergente
ATE238070T1 (de) Komplex aus carrageenan und einem wasserlöslichen medikament mit einer spezifischen granulometrie und entsprechende pharmazeutische zusammensetzungen mit gesteuerter freisetzung
DE69828426D1 (de) Verfahren zur herstellung von polymerteilchen
HUP0003330A2 (hu) Tizoxanidot és nitazoxanidot tartalmazó gyógyszerkészítmények
CA2410595A1 (en) Use of aloe-emodin in the treatment of neuroectodermal tumors
TH53082A3 (th) องค์ประกอบและวิธีการของการเตรียมอนุภาคจุลภาคของสารที่ไม่ละลายน้ำ
CO5080739A1 (es) Compuestos antibacterianos de cefalosporinas de 7-acilamino- 3-(amino-guanidina ciclica) metileno utiles como productos farmaceuticos y procesos para su produccion
FI910509A (fi) Menetelmä oraalisesti, nestemäisessä muodossa annettavan hiukkasjauheen valmistamiseksi

Legal Events

Date Code Title Description
8364 No opposition during term of opposition